Clinical Trial Update: Effects of High Cut-off (HCO) Hemodialysis on Central Memory CD4+ T and Treg Cells in Patients With End-stage Kidney Disease [Phase 2, Phase 3]

View source ↗

Summary

This document reports on an ongoing Phase 2/3 clinical trial evaluating the effects of high cut-off hemodialysis on central memory CD4+ T cells and regulatory T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Snippet

Sponsor: Centre Hospitalier du Centre du Valais | Conditions: End-stage Kidney Disease, CD4 T Cells | Phase 2, Phase 3 | Status: UNKNOWN